Management of High-Grade Dysplasia in Patients With Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 12, 2006, Pages 1434-1439

  Montgomery, Elizabeth ^a   Canto, Marcia Irene ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CASE REPORT; DYSPLASIA; ENDOSCOPIC BIOPSY; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; MALE; PATIENT REFERRAL; PHOTODYNAMIC THERAPY; TREATMENT OUTCOME;

BARRETT ESOPHAGUS; BIOPSY; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY;

EID: 33845323429     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.09.037     Document Type: Article

References (23)

1. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
2. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus: the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93 (1998) 1028-1032
3. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
4. Heitmiller R.F., Redmond M., and Hamilton S.R. Barrett's esophagus with high-grade dysplasia: an indication for prophylactic esophagectomy. Ann Surg 224 (1996) 66-71
5. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105 (1993) 40-50
6. Overholt B.F., Lightdale C.J., Wang K.K., et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 62 (2005) 488-498
7. Montgomery E., Goldblum J.R., Greenson J.K., et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 32 (2001) 379-388
8. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 120 (2001) 1607-1619
9. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32 (2001) 368-378
10. Reid B.J., Haggitt R.C., Rubin C.E., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19 (1988) 166-178
11. Sharma P., McQuaid K., Dent J., et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 127 (2004) 310-330
12. van Sandick J.W., van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
13. Levine D.S., Haggitt R.C., Blount P.L., et al. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 105 (1993) 40-50
14. Canto M.I., Setrakian S., Willis J., et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 51 (2000) 560-568
15. Canto M.I. Methylene blue chromoendoscopy for Barrett's esophagus: coming soon to your GI unit?. Gastrointest Endosc 54 (2001) 403-409
16. Kiesslich R., Gossner L., Goetz M., et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol 4 (2006) 979-987
17. Evans J.A., Poneros J.M., Bouma B.E., et al. Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol 4 (2006) 38-43
18. Kara M.A., Peters F.P., Ten Kate F.J., et al. Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus. Gastrointest Endosc 61 (2005) 679-685
19. Kara M.A., Peters F.P., Rosmolen W.D., et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 37 (2005) 929-936
20. Reid B.J., Weinstein W.M., Lewin K.J., et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94 (1988) 81-90
21. Lomo L.C., Blount P.L., Sanchez C.A., et al. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort. Am J Surg Pathol 30 (2006) 423-435
22. Montgomery E., Bronner M.P., Greenson J.K., et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus?. data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol 97 (2002) 27-31
23. Ormsby A.H., Petras R.E., Henricks W.H., et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51 (2002) 671-676